2025-05-28 REL RCSB INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY EXPERIMENTAL_SUMMARY em_admin em_software _em_admin.last_update _em_software.name STRUCTURE_SUMMARY em_admin pdbx_entry_details pdbx_validate_close_contact struct_conn struct_conn_type _em_admin.last_update _pdbx_entry_details.has_protein_modification DATA_COLLECTION em_admin em_software _em_admin.last_update _em_software.name RCSB RCSB 2023-12-04 2024-07-17 2024-07-17 2025-05-28 National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease (NIH/NIDDK) United States Cystic Fibrosis Foundation United States Phosphorylated, ATP-bound, E1371Q human cystic fibrosis transmembrane conductance regulator (E1371Q-CFTR) Gao X Hwang T cystic fibrosis, chloride channel, hydrolysis-deficient mutant, MEMBRANE PROTEIN Gao X Yeh HI Yang Z Fan C Jiang F Howard RJ Lindahl E Kappes JC Hwang TC Allosteric inhibition of CFTR gating by CFTRinh-172 binding in the pore. Nat Commun UK 15 6668 6668 2024 39107303 doi:10.1038/s41467-024-50641-1 2041-1723 EMD-43014 other EM volume 8v7z FULLOVERLAP E1371Q-CFTR E1371Q-CFTR 0 1 Homo sapiens Cystic fibrosis transmembrane conductance regulator Homo sapiens 0.161518891 1 Cricetulus griseus LEVO VVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYL GEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSR VLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQ RAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKG IILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFE KAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISF CPQFPWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFPEKDNTVLGEGGITLSGGQRAKISLARAVYKDADLYL LDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSF DQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDE PLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSR RLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQ DKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAG GILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSP IFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVG IILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQM TVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIP QKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLD QPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLL P13569 5.6.1.6 MAGNESIUM ION 2.4305e-05 2 MG ADENOSINE-5'-TRIPHOSPHATE 0.000507181 2 ATP (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate 0.0007600759999999999 5 POV CHOLESTEROL 0.000386654 1 CLR singleParticle particle 7.5 ETHANE TFS KRIOS OTHER OTHER FIELD EMISSION GUN 300 0.5 2.5 GATAN K3 (6k x 4k) 1.33375 1 NONE 3.4 FSC 0.143 CUT-OFF 261806 PROJECTION MATCHING ANGULAR RECONSTITUTION emd_43011.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 260 260 260 0 0 0 260 260 260 275.08 275.08 275.08 90.0 90.0 90.0 X Y Z -0.10573102 0.1463909 0.000017658826 0.0026991377 1.058 1.058 1.058 0.0103 AUTHOR emd_43011_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 260 260 260 0 0 0 260 260 260 275.08 275.08 275.08 90.0 90.0 90.0 X Y Z -0.02701655 0.043458972 0.0000098649425 0.0011537431 1.058 1.058 1.058 AUTHOR emd_43011_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 260 260 260 0 0 0 260 260 260 275.08 275.08 275.08 90.0 90.0 90.0 X Y Z -0.026034152 0.04130791 0.000009904303 0.0011392696 1.058 1.058 1.058 AUTHOR